UK sets up an AI Biosecurity Lab with £100M of public money and up to £200M from OpenAI and Anthropic

The UK government is setting up an AI Biosecurity Lab (AIBL), announced by the Cabinet Office on 24 October. It is backed by £100 million of government funding and up to £200 million in commitments from OpenAI and Anthropic. The government calls it “the world’s first dedicated AI biosecurity organisation.”

The pitch cuts both ways. The announcement says AI can speed up disease research and the discovery of medical countermeasures, but that more capable systems “could lower barriers to harmful activity.” The lab’s job is to use frontier AI on the defensive side.

What it will work on

AIBL’s first work will focus on two things:

1. Earlier detection of emerging biological threats.
2. Faster development of vaccines, treatments and other medical countermeasures.

It will work with the UK’s national biosecurity centres and the life sciences industry. It is part of a National AI Biosecurity Initiative alongside the UK Health Security Agency (UKHSA), the Animal and Plant Health Agency (APHA) and the Defence Science and Technology Laboratory (Dstl). It will also work with the medicines regulator, the MHRA, on health-emergency preparation and on informing the regulation of AI-designed medicines.

Who is putting in what

• UK government: £100 million.
• OpenAI: £100 million in compute and model credits, plus trusted access to its most capable relevant models through its Rosalind Biodefense programme.
• Anthropic: up to £100 million in model credits, trusted model access and dedicated technical support.
• Google DeepMind: research collaborations, and it “will look to provide” trusted access to frontier Gemini and specialised science models.
• Basecamp Research: access to its AI biology models and expertise.

Note that most of the company money is credits and access, not cash. The government also says it wants philanthropic funding over time.

How it is set up

AIBL will be an independent non-profit. The government compares it to the AI Security Institute: it should hire top industry and academic technical staff and have enough autonomy to move with the speed and focus of a frontier AI and biology company. A scientific advisory committee from academia, industry and the third sector is promised, with details “in due course.”

What is missing

The page names no director, location, headcount or start date, and gives no split of the £100 million over time. It also does not say how the lab will handle the dual-use risk of the research itself, which is the heart of AI biosecurity work. Those are the details to watch for.

Practical takeaway

If you work in UK life sciences or biosecurity, this is a new partner with frontier-model access through OpenAI, Anthropic and Google DeepMind. For everyone else, it is another sign that labs are pairing model access with government security work, here in biology rather than cyber.